Aralez Pharmaceuticals Inc (ARZ) Trading 9.5% Higher
Aralez Pharmaceuticals Inc (TSE:ARZ) traded up 9.5% during trading on Wednesday . The stock traded as high as C$3.24 and last traded at C$3.11. 86,323 shares changed hands during trading, an increase of 36% from the average session volume of 63,247 shares. The stock had previously closed at C$2.84.
The company’s 50 day moving average is $2.24 and its 200-day moving average is $2.24. The stock’s market capitalization is $204.55 million.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/06/aralez-pharmaceuticals-inc-arz-trading-9-5-higher.html.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Stock Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.